Among Doctors

First patient dosed in BioNTech Phase II trial of mRNA cancer vaccine BioNTech has announced that it has commenced dosing in it's BNT111 Phase II cancer vaccine trial in advanced melanoma.

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer announced positive early results from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed.